Pioglitazone is associated with an increased risk for incident bladder cancer among persons with type 2 diabetes, according to the results of a nested case-control study published online May 31 in the British Medical Journal. Risk doubled in patients treated with pioglitazone for 2 years or more.Lose the weight.
Lose the clinical diabetes.
Lose the risk from the drugs.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.